At Emulate, Inc., our team is pioneering the commercialization of innovative, once in a generation, in vitro biological models that are reshaping drug discovery. With over two years at the helm as Chief Scientific Officer, my role encompasses leading scientific strategies, guiding biological and platform product development, and executing bespoke research for biotech and pharma partners. Collaborating with academics and regulatory authorities enhances our reach and impact in the field.My commitment to advancing human-centric models for drug efficacy and safety is rooted in my extensive background in pharmacology, toxicology and cell biology. This passion was ignited during my tenure at AstraZeneca, where I contributed to multidisciplinary teams focused on discovery bioscience and safety assessment. Now, with a position on Carcinotech's board, a MedTech company manufacturing 3D printed mini tumours, I am leveraging my expertise to influence the broader scientific community in translational science.